The Artificial Intelligence and Digital Health Revolution and the Impact on FDA Policy on Devices and Drugs – Events

The development of artificial intelligence (AI), machine learning (ML), and other digital health technologies has the potential to revolutionize health care delivery and accelerate the development of new medical products, including both pharmaceuticals and medical devices.

Given the increasing use of these advanced technologies in the medical space, the U.S. Food and Drug Administration (FDA) is working hard to ensure its regulatory policies are up to date. This webinar will discuss how the FDA regulates digital health technologies (including AI/ML) for health-related applications, recent FDA developments related to AI/ML, and FDA policies related to the use of AI/ML in research and development activities. development related to pharmaceutical products and medical devices.

CLE credit: CLE credit in CA, IL, NY, PA, TX, VA and WA is currently pending approval; CT, FL and NJ (reciprocal).